Problematic internet use: an exploration of associations between cognition and COMT rs4818, rs4680 haplotypes.


Journal

CNS spectrums
ISSN: 1092-8529
Titre abrégé: CNS Spectr
Pays: United States
ID NLM: 9702877

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 5 6 2019
medline: 25 8 2021
entrez: 5 6 2019
Statut: ppublish

Résumé

Problematic internet users suffer from impairment in a variety of cognitive domains. Research suggests that COMT haplotypes exert differential effects on cognition. We sought to investigate differences in the genetic profiles of problematic internet users and whether those could shed light on potential cognitive differences. We recruited 206 non-treatment seeking participants with heightened impulsive traits and obtained cross-sectional demographic, clinical, and cognitive data as well as the genetic haplotypes of COMT rs4680 and rs4818. We identified 24 participants who presented with problematic internet use (PIU) and compared PIU and non-PIU participants using one-way analysis of variance (ANOVA) and chi square as appropriate. PIU was associated with worse performance on decision making, rapid visual processing, and spatial working memory tasks. Genetic variants were associated with altered cognitive performance, but rates of PIU did not statistically differ for particular haplotypes of COMT. This study indicates that PIU is characterized by deficits in decision making and working memory domains; it also provides evidence for elevated impulsive responses and impaired target detection on a sustained attention task, which is a novel area worth exploring further in future work. The effects observed in the genetic influences on cognition of PIU subjects imply that the genetic heritable components of PIU may not lie within the genetic loci influencing COMT function and cognitive performance; or that the genetic component in PIU involves many genetic polymorphisms each conferring only a small effect.

Identifiants

pubmed: 31159911
pii: S1092852919001019
doi: 10.1017/S1092852919001019
pmc: PMC7292732
mid: EMS82639
doi:

Substances chimiques

COMT protein, human EC 2.1.1.6
Catechol O-Methyltransferase EC 2.1.1.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-418

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110049
Pays : United Kingdom

Références

J Behav Addict. 2017 Dec 1;6(4):545-553
pubmed: 29052999
Addict Behav. 2018 Jun;81:157-166
pubmed: 29459201
Front Behav Neurosci. 2014 Aug 25;8:288
pubmed: 25202248
Behav Res Ther. 1996 Feb;34(2):163-73
pubmed: 8741724
Psychiatry Res. 2013 Apr 30;206(2-3):217-22
pubmed: 23273609
Neuropsychologia. 2008 Jan 31;46(2):757-63
pubmed: 18037454
Psychopathology. 2013;46(1):1-13
pubmed: 22854219
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Pharmacogenomics J. 2016 Oct;16(5):430-8
pubmed: 27241058
Biol Psychiatry. 2012 Mar 15;71(6):538-44
pubmed: 22364739
J Affect Disord. 2008 Jul;109(1-2):165-9
pubmed: 18045695
J Behav Addict. 2014 Dec;3(4):246-53
pubmed: 25592310
Twin Res Hum Genet. 2014 Aug;17(4):279-87
pubmed: 24933598
J Behav Addict. 2016 Dec;5(4):631-638
pubmed: 27826991
Front Behav Neurosci. 2015 Nov 03;9:296
pubmed: 26578922
Am J Psychiatry. 2005 Nov;162(11):2184-8
pubmed: 16263865
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Arch Neurol. 2007 Nov;64(11):1575-9
pubmed: 17998440
Neuropsychologia. 1990;28(10):1021-34
pubmed: 2267054
Addict Biol. 2013 Jan;18(1):134-46
pubmed: 22970898
Annu Rev Neurosci. 2009;32:267-87
pubmed: 19555290
J Addict Med. 2007 Sep;1(3):133-8
pubmed: 21768948
Psychopharmacology (Berl). 2009 Nov;207(1):163-72
pubmed: 19727677
Biol Psychiatry. 2009 Dec 1;66(11):997-1004
pubmed: 19699472
Science. 2006 Dec 22;314(5807):1930-3
pubmed: 17185601
Eur Neuropsychopharmacol. 2018 Nov;28(11):1232-1246
pubmed: 30509450
Addict Biol. 2016 Mar;21(2):460-8
pubmed: 25582809
Trends Cogn Sci. 2004 Apr;8(4):170-7
pubmed: 15050513
Eur Psychiatry. 2012 Jan;27(1):1-8
pubmed: 22153731
J Addict Med. 2012 Sep;6(3):191-5
pubmed: 22722381
Neuroreport. 2011 Jun 11;22(8):407-11
pubmed: 21499141
Addict Behav. 2017 Feb;65:137-146
pubmed: 27816039
J Psychiatr Res. 2016 Dec;83:94-102
pubmed: 27580487
CNS Spectr. 2017 Feb;22(1):22-30
pubmed: 27680974
BMC Psychiatry. 2014 Jun 20;14:183
pubmed: 24947851
J Behav Addict. 2018 Jun 1;7(2):269-275
pubmed: 29788748
Neurosci Lett. 2011 Jul 20;499(2):114-8
pubmed: 21645588
Front Psychol. 2016 Mar 17;7:370
pubmed: 27014170
World J Psychiatry. 2016 Mar 22;6(1):143-76
pubmed: 27014605
Neuropharmacology. 2009 Feb;56(2):493-8
pubmed: 18983999
Psychiatry Res. 2011 Aug 15;188(3):428-33
pubmed: 21641048
Medicine (Baltimore). 2016 Dec;95(50):e5695
pubmed: 27977620
J Psychiatr Res. 2015 Sep;68:371-6
pubmed: 26028545
Am J Hum Genet. 2004 Nov;75(5):807-21
pubmed: 15457404
Biochemistry. 1995 Apr 4;34(13):4202-10
pubmed: 7703232
PLoS One. 2017 Dec 14;12(12):e0188358
pubmed: 29240768
Mol Med Rep. 2013 Apr;7(4):1067-72
pubmed: 23440431
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Br J Psychiatry. 2019 Feb 20;:1-8
pubmed: 30784392
Acta Neuropsychiatr. 2016 Apr;28(2):92-100
pubmed: 26400106
Am J Psychiatry. 1999 Jan;156(1):34-40
pubmed: 9892295
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3109-11
pubmed: 18640913
J Biomed Biotechnol. 2012;2012:854524
pubmed: 22505818
J Behav Addict. 2016 Sep;5(3):510-7
pubmed: 27554505
CNS Spectr. 2017 Dec;22(6):495-503
pubmed: 28893336
Psychol Med. 2014 Jan;44(2):435-46
pubmed: 23561037

Auteurs

Konstantinos Ioannidis (K)

Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
Cambridge and Peterborough NHS Foundation Trust, Cambridge, United Kingdom.

Sarah A Redden (SA)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois, USA.

Stephanie Valle (S)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois, USA.

Samuel R Chamberlain (SR)

Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
Cambridge and Peterborough NHS Foundation Trust, Cambridge, United Kingdom.

Jon E Grant (JE)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH